Government Advocacy March 15, 2018: MGMA comment on the MedPAC March 2018 report to Congress Advocacy Statement Government Programs Sign in to save March 15, 2018 Attribute to Anders Gilberg, SVP MGMA Government Affairs WASHINGTON, D.C. – “MedPAC’s March Report is an indictment of MIPS as implemented. However, its conceptual “VVP” alternative lacks details. MGMA believes there are steps that can be taken now to reduce clinician burden. CMS can begin by shortening the 2018 MIPS data reporting period from one-year to 90 days in the same way the Agency did for Meaningful Use in 2014, 2015, and 2016.”